Reportlinker.com announces that a new market research report is available in its catalogue: Proteomics: Technologies and Global Markets
STUDY GOALS AND OBJECTIVES
BCC Research's goal for this study was to determine the status of proteomic technologies and products and assess their global growth potential over the five-year period from 2012 to 2017. The market was analyzed for the main proteomic platforms: mass spectrometry and biochips.
The biochip market was characterized by key biochip type (i.e., lab-on-a-chip, planar array, bead array) and by end-use industry (e.g., research, drug discovery and development, diagnostics, applied).
The mass spectrometry (MS) market was characterized by MS instrument type and end-use industry, as well as by MS workflow (e.g., sample preparation, chromatography, tagging and labeling reagents, and informatics).
A particular focus of the study is placed on the market for proteomic-based diagnostics products, which highlights a major future market segment for proteomic technologies.
The key objective was to present a comprehensive discussion of the main commercial proteomic technologies, along with the current and future commercial potential for each of the key market segments.
REASONS FOR DOING THE STUDY
BCC Research has previously examined the proteomic industry as part of several larger studies. For example, BCC published a report on biochips in 2011 that covered protein arrays and lab-on-a-chip (LOAC) products and markets. In 2010, BCC published a report on next-generation cancer diagnostics that covered diagnostics applications for proteomic biochips.
The main objective for the present report is to present the up-to-date market picture for proteomics into a single comprehensive report. The objective was to capture the changing industry dynamics and market shift occurring in this industry. Thus, it is timely to examine the key aspects of the proteomic industry.
There is also an urgent need in the life science industry for technologies and products that can analyze and study the human proteome in a high-throughput, multiplex and low-cost way. Proteomic technologies are evolving to meet more of these needs, so it is important to keep abreast of these dynamics.
This report is intended to inform companies in the life science industries regarding the important trends in MS, LOAC and arrays, as well as to provide detailed information concerning the individual market segments and industry dynamics.
CONTRIBUTION OF THE STUDY AND INTENDED AUDIENCE
BCC has compiled a study of critical proteomic technologies that are used in the four major end-user segments: research, drug discovery and development, diagnostics and applied markets. The report discusses the proteomic platforms, market growth driving forces, product types, key market applications, companies and alliances, industry dynamics, patents, future market potential and product sales forecasts for the period from 2012 through 2017.
This study will be of particular interest to the companies in such industries as diagnostics, pharmaceuticals, biotechnology, nanotechnology, life sciences tools, biodefense, medical devices, analytical instruments, chromatography, chemicals, polymers, glass and bioinformatics. It will also be of interest to companies involved in drug, diagnostic and/or biomarker discovery programs; manufacturers of microarrays and lab-on-a-chip devices; sample prep suppliers; bioinformatics developers; and cancer researchers and clinicians.
SCOPE AND FORMAT
The study scope covers MS instruments, consumables, workflow products, planar arrays, bead arrays and LOAC. It also covers the research, drug discovery and development, diagnostics and applied end-user market segments. The main geographical markets—North America, Europe, Japan and Rest of World (ROW)—are included.
The MS market is covered by instrument type, MS consumables, product type and end-user markets. The biochip market is covered by biochip type and the-end user market for each type. The diagnostics market is covered in some detail, including by major platform (i.e., MS, biochips), by disease type and for cancer by indication.
This report provides the current market sizes for these segments, as well as their forecasted growth through 2017.
Technology status and market driving forces are discussed. Factors that influence each market are also discussed, including growth-driving forces, industry alliances and acquisitions, applications in diagnostics and drug discovery, customer needs and competitive trends.
Key industry acquisitions and strategic alliances are given for the three-year period from 2010 through 2012.
This report also examines the main patent trends within the industry and profiles 83 companies.
Both primary and secondary research methodologies were used in preparing this study. BCC Research examines the key end-user market segments that will be commercially important during the next five years:
Drug discovery and development.
Applied markets (e.g., forensics, agriculture, environmental).
Based on this analysis, the potential applications of proteomic technologies in each of the major market segments were evaluated, and sales revenues were forecast for the period from 2012 through 2017.
Based on the analysis of both secondary and primary market sources, as well as the key trends in the industry, current and projected market sizes are provided for the various proteomic segments for 2011, 2012 and 2017.
Primary sources for this report included key industry companies and leading research institutions. Data were also compiled from secondary sources, including company websites and industry, trade and government publications.
John Bergin has written previous BCC Research biotechnology reports, including Epigenomics: Emerging Opportunities in Biomarkers, Diagnostics and Therapeutics; Global Biochip Markets: Microarrays and Lab-on-a-chip; RNA Interference in the Post-Genomic Era: Markets and Technologies; DNA Sequencing: Emerging Technologies and Applications; Biologic Imaging Reagents: Technologies and Global Markets; and Synthetic Biology: Emerging Global Markets. Mr. Bergin has held business development, sales and marketing positions with a Fortune 500 advanced materials company, as well as executive management positions with an emerging nanotechnology company. Mr. Bergin holds a BS in Chemistry, an MS in Biotechnology and a Masters of Business Administration.
This report provides:
An overview of the global proteomics market, which covers: technologies, database and software markets, equipment markets, application markets and service markets.
Analyses of global market trends, with data from 2011 and 2012, and projections of compound annual growth rates (CAGRs) through 2017.
Discussion of trends and opportunities, top-selling products, key players, and a competitive outlook.
Comprehensive company profiles across subsegments, such as protein chip providers, reagent providers, service providers, informatics and database providers, etc.